Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001839292 | SCV002099277 | uncertain significance | Noonan syndrome 4 | 2021-04-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359275 | SCV002620179 | uncertain significance | Cardiovascular phenotype | 2022-03-10 | criteria provided, single submitter | clinical testing | The p.T1269R variant (also known as c.3806C>G), located in coding exon 23 of the SOS1 gene, results from a C to G substitution at nucleotide position 3806. The threonine at codon 1269 is replaced by arginine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV001839292 | SCV002763201 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468328 | SCV002763202 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |